164 related articles for article (PubMed ID: 24206267)
1. Computational selection and experimental validation of allosteric ribozymes that sense a specific sequence of human telomerase reverse transcriptase mRNAs as universal anticancer therapy agents.
Penchovsky R; Kostova GT
Nucleic Acid Ther; 2013 Dec; 23(6):408-17. PubMed ID: 24206267
[TBL] [Abstract][Full Text] [Related]
2. GHOST-NOT and GHOST-YES: Two programs for generating high-speed biosensors with randomized oligonucleotide binding sites with NOT or YES Boolean logic functions based on experimentally validated algorithms.
Kaloudas D; Pavlova N; Penchovsky R
J Biotechnol; 2023 Aug; 373():82-89. PubMed ID: 37499876
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
4. Computational design of allosteric ribozymes as molecular biosensors.
Penchovsky R
Biotechnol Adv; 2014; 32(5):1015-27. PubMed ID: 24877999
[TBL] [Abstract][Full Text] [Related]
5. Computational design and experimental validation of oligonucleotide-sensing allosteric ribozymes.
Penchovsky R; Breaker RR
Nat Biotechnol; 2005 Nov; 23(11):1424-33. PubMed ID: 16244657
[TBL] [Abstract][Full Text] [Related]
6. An allosteric ribozyme generator and an inverse folding ribozyme generator: Two computer programs for automated computational design of oligonucleotide-sensing allosteric hammerhead ribozymes with YES Boolean logic function based on experimentally validated algorithms.
Kaloudas D; Penchovsky R
Comput Biol Med; 2022 Jun; 145():105469. PubMed ID: 35398809
[TBL] [Abstract][Full Text] [Related]
7. Computational Design of Allosteric Ribozymes via Genetic Algorithms.
Kaloudas D; Pavlova N; Penchovsky R
Methods Mol Biol; 2024; 2822():443-469. PubMed ID: 38907934
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M
Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398
[TBL] [Abstract][Full Text] [Related]
9. A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation.
Li QX; Robbins JM; Welch PJ; Wong-Staal F; Barber JR
Nucleic Acids Res; 2000 Jul; 28(13):2605-12. PubMed ID: 10871412
[TBL] [Abstract][Full Text] [Related]
10. In vitro selection of allosteric ribozymes: theory and experimental validation.
Piganeau N; Thuillier V; Famulok M
J Mol Biol; 2001 Oct; 312(5):1177-90. PubMed ID: 11580234
[TBL] [Abstract][Full Text] [Related]
11. Selection of targets and the most efficient hairpin ribozymes for inactivation of mRNAs using a self-cleaving RNA library.
Barroso-DelJesus A; Berzal-Herranz A
EMBO Rep; 2001 Dec; 2(12):1112-8. PubMed ID: 11743025
[TBL] [Abstract][Full Text] [Related]
12. Selection in vitro of allosteric ribozymes.
Roth A; Breaker RR
Methods Mol Biol; 2004; 252():145-64. PubMed ID: 15017047
[TBL] [Abstract][Full Text] [Related]
13. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
14. Structural diversity of self-cleaving ribozymes.
Tang J; Breaker RR
Proc Natl Acad Sci U S A; 2000 May; 97(11):5784-9. PubMed ID: 10823936
[TBL] [Abstract][Full Text] [Related]
15. Allosteric selection of ribozymes that respond to the second messengers cGMP and cAMP.
Koizumi M; Soukup GA; Kerr JN; Breaker RR
Nat Struct Biol; 1999 Nov; 6(11):1062-71. PubMed ID: 10542100
[TBL] [Abstract][Full Text] [Related]
16. Engineered allosteric ribozymes that sense the bacterial second messenger cyclic diguanosyl 5'-monophosphate.
Gu H; Furukawa K; Breaker RR
Anal Chem; 2012 Jun; 84(11):4935-41. PubMed ID: 22519888
[TBL] [Abstract][Full Text] [Related]
17. Design of allosteric hammerhead ribozymes activated by ligand-induced structure stabilization.
Soukup GA; Breaker RR
Structure; 1999 Jul; 7(7):783-91. PubMed ID: 10425680
[TBL] [Abstract][Full Text] [Related]
18. Engineering high-speed allosteric hammerhead ribozymes.
Link KH; Guo L; Ames TD; Yen L; Mulligan RC; Breaker RR
Biol Chem; 2007 Aug; 388(8):779-86. PubMed ID: 17655496
[TBL] [Abstract][Full Text] [Related]
19. Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences.
Pachuk CJ; Yoon K; Moelling K; Coney LR
Nucleic Acids Res; 1994 Feb; 22(3):301-7. PubMed ID: 8127665
[TBL] [Abstract][Full Text] [Related]
20. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
